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ARTICLE
Airway response to respiratory syncytial virus has
incidental antibacterial effects
Charles J. Sande 1,2,6, James M. Njunge 1,6, Joyce Mwongeli Ngoi1, Martin N. Mutunga1, Timothy Chege1,
Elijah T. Gicheru1, Elizabeth M. Gardiner1, Agnes Gwela1, Christopher A. Green2, Simon B. Drysdale2,
James A. Berkley 1,3,4, James Nokes 1,5 & Andrew J. Pollard2
RSV infection is typically associated with secondary bacterial infection. We hypothesise that
the local airway immune response to RSV has incidental antibacterial effects. Using coor-
dinated proteomics and metagenomics analysis we simultaneously analysed the microbiota
and proteomes of the upper airway and determined direct antibacterial activity in airway
secretions of RSV-infected children. Here, we report that the airway abundance of Strepto-
coccus was higher in samples collected at the time of RSV infection compared with samples
collected one month later. RSV infection is associated with neutrophil inﬂux into the airway
and degranulation and is marked by overexpression of proteins with known antibacterial
activity including BPI, EPX, MPO and AZU1. Airway secretions of children infected with RSV,
have signiﬁcantly greater antibacterial activity compared to RSV-negative controls. This RSV-
associated, neutrophil-mediated antibacterial response in the airway appears to act as a
regulatory mechanism that modulates bacterial growth in the airways of RSV-infected
children.
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Respiratory tract infections are a major cause of morbidityand mortality globally1,2. In 2015, acute lower respiratoryinfections (ALRI) due to respiratory syncytial virus (RSV)
resulted in an estimated 33.1 million disease episodes, 3.2 million
hospitalisations and 118,200 deaths in children younger than the
age of 5 years3. A common complication of respiratory virus
infection is secondary bacterial infection; viruses such as inﬂu-
enza, RSV and parainﬂuenza often predispose the host to sec-
ondary respiratory disease caused by pathobionts, such as
Streptococcus pneumoniae, Haemophilus inﬂuenzae and Staphy-
lococcus aureus4–8, leading to serious, potentially life-threatening
sequelae9. Secondary bacterial complications are thought to have
been the major cause of the fatalities that occurred in the wake
of the major inﬂuenza pandemics of the 20th and early 21st
century8,10,11. In the case of RSV, there is a strong link between
virus infection and secondary bacterial infections, particularly
otitis media caused by S. pneumoniae and H. inﬂuenzae12–14.
Although the molecular and cellular basis for this co-pathogenesis
is not fully understood, evidence from in vitro studies suggests
that RSV infection of respiratory epithelial cell lines, such as
HEp-2 and A549 facilitates increased adhesion of bacteria such as
S. pneumoniae and H inﬂuenzae15–18, and suggests that RSV
infection in vivo increases the capacity of these bacteria to colo-
nise the airway. These observations are supported by results from
clinical studies which show that the upper airway microbiota of
children with RSV infection is signiﬁcantly enriched for H.
inﬂuenzae and Streptococcus19,20. The host response to RSV
infection is characterised by the recruitment of innate immune
cells21 and the release of inﬂammatory cytokines, such as IL-17A
and other soluble mediators22. To date, no studies have examined
whether the immune response triggered by replication of RSV in
the airway has simultaneous antibacterial activity, aimed at con-
trolling increased bacterial colonisation resulting from viral
infection. Here we report the simultaneous analysis of the upper
airway proteomes and microbiota of infants and children with
and without RSV infection to determine whether elements of the
innate immune response to RSV infection in the human airway
has incidental antibacterial activity. Using shotgun proteomics,
we ﬁnd that the local airway response that followed RSV infection
is characterised by a strong neutrophil response, which has direct
antibacterial properties.
Results
Characteristics of the study population. Nasopharyngeal and
oropharyngeal swabs obtained from 84 children with (n= 40)
and without (n= 44) RSV infection were included in the analysis.
Baseline characteristics of the study population are described in
Table 1. In the RSV-positive group, only children with a positive
laboratory diagnosis of RSV and negative for other common
respiratory viruses andMycoplasma pneumoniae were included in
the analysis, while the RSV-negative group comprised children
who were negative for RSV and other infectious causes of
respiratory illness (see “Methods” for further details). The groups
were well-matched and no statistically signiﬁcant differences in
clinical and anthropometric measures were identiﬁed. Only
children to whom antibiotics had not been administered in the
2 weeks prior to sampling were recruited.
The upper airway is dominated by Streptoccocal colonisation.
Sequence analysis of the V3–V4 regions of the 16S rRNA bac-
terial gene generated a total of 6,622,832 high-quality reads
(median 83,831 IQR 39,686–107,741). The top 10 taxa in the
airway microbiome by median proportional abundance were
Streptococcus, Veillonella, Haemophilus, Prevotella, Neisseria,
Escherichia, Staphylococcus, Corynebacterium, Moraxella, and
Leptotrichia (Fig. 1a). Streptococcus was the most abundant taxon
with a median proportional abundance of ~40% (Supplementary
Fig. 1). Simultaneous bacterial metaproteome analysis using mass
spectrometry showed a similar proﬁle of microbial diversity and
was equally dominated by Streptococcal proteins (Fig. 1b). Most
of the bacterial proteins in the metaproteome were ribosomal
proteins, including 50S and 30S proteins as well proteins involved
in energy metabolism, such as pyruvate oxidase and enolase.
Further analysis of the genomic microbiota data was undertaken
to determine whether the airway replication of RSV had an effect
on the most abundant bacterial taxon (Streptococcus). Changes in
Streptococcus abundance during and after RSV infection were
calculated in a subset of RSV-infected children (n= 10) for whom
nasal samples were collected at admission (acute samples) and
~1 month later (convalescent samples). For 70% of these children
(7/10), the airway abundance of Streptococcus during acute
infection was higher than that at convalescence, while for three
children (3/10), Streptococcus abundance at convalescence was
either not different or had increased, relative to the acute infec-
tion time point (Fig. 1c).
RSV infection results in airway neutrophil degranulation. In
order to characterise biological pathways that are upregulated in
the local airway following RSV infection, the mean expression
levels of airway proteins were compared between children with
and without RSV infection. Of the 1875 host proteins that were
quantiﬁed in the upper airway, the mean expression levels of 123
proteins were signiﬁcantly different between the two groups of
children (Supplementary data 2). Among these, 73 proteins were
expressed at signiﬁcantly higher levels in children with RSV
infection while the remainder were higher among those without
RSV infection (Fig. 2a). Gene ontology biological process
(GOBP)-based enrichment analysis of these differentially
expressed proteins showed that the neutrophil degranulation
pathway (GOBP ID: 0043312, combined enrichment score=
401.9) was the most signiﬁcantly enriched biological process
among RSV-infected children (adjusted Fishers exact test P=
9.5 × 10−31, Fig. 2b). Other pathways such as proteolysis were
also signiﬁcantly enriched in the airways of RSV-infected children
but their respective enrichment scores were much lower than the
neutrophil degranulation pathway (combined enrichment scores
of ≤ 35.1) (Fig. 2b). The neutrophil degranulation pathway com-
prised 33 proteins—including bactericidal proteins that are
typically localised within neutrophil granules, such as MPO,
Table 1 Comparison of clinical and anthropometric characteristics of study participants
RSV-negative (n= 44) RSV-positive (n= 40) P-value
Age (months) 3.0 (0.03–51.3) 3.9 (0.4–45.8) 0.7
Weight (kg) 4.6 (1.8–14.2) 5.6 (2.0–13.6) 0.15
Length (cm) 61.0 (44.0–99.2) 61.0 (47.0–95.0) 0.2
Oxygen saturation (%) 98 (57–100) 93 (67–100) 0.07
Respiratory rate (breaths per minute) 56 (30–99) 53 (11–85) 0.6
Axillary temperature (°C) 37.7 (34.0–40.2) 37.2 (35.7–39.6) 0.9
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AZU1, BPI, LCN2, and others (Fig. 2d). In addition to neutrophil
granule proteins, we also observed elevated expression of other
potent antibacterial proteins in RSV-infected children; the mean
expression levels of eosinophil peroxidase (EPX) and Ras-related
protein (RAP1B) were signiﬁcantly higher in RSV-infected chil-
dren than in RSV-negative controls (Fig. 2d). Among children
without RSV infection, SRP-dependent co-translational protein
targeting to membrane, signal sequence recognition (GOBP ID:
0006617, adjusted Fishers exact test P= 1.02 × 10−8, Fig. 2c) was
the most signiﬁcantly enriched pathway.
Secretions from infected children inhibit microbial growth.
Due to the signiﬁcant overexpression of antibacterial proteins in
the airway secretions of RSV-infected children, we reasoned that
these children would have substantially greater antibacterial
activity compared with children without RSV infection. To test
this hypothesis, we developed an in vitro assay to measure the
bacterial inhibition activity against a common nasopharyngeal
pathobiont, S. pneumoniae. Anti-pneumococcal activity was
tested in nasal samples from children with and without RSV
infection and data presented as a bacterial inhibition index (BII),
whose values ranged from 0 (no inhibition) to 40,960 (complete
inhibition) (Fig. 3a). Children were binned into ﬁve BII strata
(BII: ≤20, 40, 80, 160 and ≥320) and the relative proportions of
different OTUs was determined within each group. The propor-
tional abundance of Streptococcus decreased with increasing BII,
with children who had the lowest anti-pneumococcal activity
(BII: ≤20) having the highest mean airway abundance of Strep-
tococcus (45%) while those with the highest anti-pneumococcal
activity (BII ≥ 320) had the lowest Streptococcus abundance (25%)
(Fig. 3b and Supplementary Fig. 4).
We then analysed the correlation between the anti-
pneumococcal activity measured in the bacterial inhibition assay
and the expression levels of 15 neutrophil granule proteins that
were signiﬁcantly overexpressed in children with RSV infection
(highlighted in Fig. 3d). We stratiﬁed this correlation analysis
by neutrophil granule subset and included two representative
members of each subset (MPO and AZU1 for azurophilic
granules, LCN2 and ITGAM for speciﬁc granules, and MMP9
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Fig. 1 The composition of the airway microbiota. a Dendrogram visualising the hierarchical clustering of individual microbiomes of 84 individual children on
the basis of the Bray–Curtis dissimilarity matrix. The relative abundance of the 15 highest-ranked operational taxonomic units are presented for each study
participant as stacked bar charts. operational taxonomic units under the ‘others’ heading are an aggregate of bacteria that occurred at low abundances
(<1%). The taxonomic identities of these low-abundance operational taxonomic units are presented in Supplementary Data 1. b The proteome of the upper
airway microbiota (metaproteome) was characterised by mass spectrometric analysis using airway samples from 84 children and the results are presented
in a circular bar chart. Each bar represents the mean expression level of one bacterial protein. Values on the y-axis correspond to MS protein expression
levels (log10 reporter corrected intensity). Most of the bacterial operational taxonomic units that were identiﬁed in metagenomic analyses of the airway
microbiota were also identiﬁed in the proteome. The highest number of protein identiﬁcations belonged to the genus Streptococcus and comprised mainly of
ribosomal proteins and proteins involved in energy metabolism pathways. c The abundance of Streptococcus in the airway was compared between RSV-
positive and RSV-negative children. RSV-infected children had a higher abundance of airway Streptococcus compared to RSV-negative children. d The
effect of RSV infection on Streptococcal colonisation of the upper airway was characterised using a subset of 10 children from whom nasopharyngeal and
oropharyngeal swabs were obtained during acute RSV infection and at convalescence, approximately one month later. Seven out of 10 children (70%)
exhibited declines in the airway abundance of Streptococcus upon recovery from RSV, while for three children, convalescent-stage Streptococcus abundance
was either unchanged from the acute time point or was higher. On the box and whisker plot, the bottom line on the box denotes the 25th data percentile
(quartile 1), the middle line denotes the median and the upper line denotes the 75th data percentile (quartile 3). The bottom whisker represents data in the
lower extremity of the distribution (quartile 1–1.5 × interquartile range) and upper whisker denotes the upper extremity of the distribution (quartile 3+
1.5 × interquartile range). Source data are provided as a Source Data ﬁle
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Fig. 2 Analysis of the airway proteome by tandem mass spectrometry. Analysis of airway proteomes was undertaken using mass spectrometry in a
population of 40 children with RSV infection and 44 RSV-negative children. a Differences in the mean expression levels of local airway proteins between
the RSV-positive and RSV-negative children was analysed using two-sided Student's t-tests and presented in a volcano plot. The y-axis represents −log10
fdr-adjusted P values (q values) computed using two-sided Student's t-tests and the x-axis represents −log10 fold change in protein expression. Red circles
represent differentially expressed proteins (deﬁned by q values: ≤0.05 and ≥1.5-fold change in expression between groups). Red circles in the top left and
top right quadrants represent proteins that were signiﬁcantly elevated in RSV-positive and RSV-negative children, respectively. b, c Gene ontology (GO)-
based biological pathways analysis was used to identify biological processes that were signiﬁcantly overrepresented in RSV-positive and RSV-negative
children. Those that were signiﬁcantly overrepresented in RSV-positive children are shown in b while those that were overrepresented in RSV-negative
children are shown in c. Adjusted P-values in b and c were calculated on the enrichR platform and are based on the Fishers extract test. The most
signiﬁcantly enriched pathway in RSV-positive children was neutrophil degranulation and in RSV-negative children was SRP-dependent co-translational
protein targeting to membrane, signal sequence recognition. d, e The speciﬁc proteins that were signiﬁcantly differentially expressed within those pathways
are shown in d and e, respectively. The proteins highlighted with the red boxes in d are neutrophil granule proteins. The elements of the box and whisker
plots are deﬁned in Fig. 1. Source data are provided as a Source Data ﬁle
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and CTSS for gelatinase granules) (Fig. 3c). We observed a
signiﬁcant positive correlation between the expression level of all
neutrophil granule proteins and pneumococcal inhibition activity
(Fig. 3c and Supplementary Fig. 2). Expression levels of three
housekeeping proteins: beta-actin (ACTB), beta-2-microglobulin
(B2M) and peptidylprolyl isomerase A (PPIA) were used as
controls and their respective expression levels did not correlate
with bacterial inhibition activity (Fig. 3c).
We then compared pneumococcal inhibition activity between
RSV-positive and RSV-negative children. Airway secretions of
RSV-infected children had signiﬁcantly greater bacterial inhibi-
tion activity (BII geometric mean: 52) compared to RSV-negative
children (BII geometric mean: 10.9, Mann–Whitney test P-value
= 0.004) (Fig. 3d). Further analysis of a subset of RSV-infected
children for whom paired acute and convalescent samples were
collected showed a similar relationship: airway secretions sampled
at the time of infection, had signiﬁcantly greater bacterial
inhibition activity compared to samples collected a month later,
during convalescence (Supplementary Fig. 3). To determine
whether this difference could be explained by differences in the
mean levels of pneumococcus-speciﬁc antibody between RSV-
positive and RSV-negative children, we measured the levels of
airway anti-pneumococcus IgG to two pneumococcal proteins
(choline-binding protein D and Histidine triad protein E). The
results of these analyses showed that the mean IgG levels to these
proteins was not signiﬁcantly different between RSV-positive and
RSV-negative children (Fig. 3e).
RSV infection is associated with neutrophil phagocytosis. We
used ﬂow cytometry to characterise airway-resident neutrophils,
which are the source of the neutrophil granule proteins that were
identiﬁed in the proteomic analysis (see “Methods” and Supple-
mentary Fig. 5 for a full description of the FACS analysis and
gating strategy). We also used ﬂow cytometry to assess the
functional activity of these cells in RSV-positive and RSV-
negative children. In RSV-infected children, neutrophils occurred
at a median frequency of 12% while in RSV-negative children,
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Fig. 3 Analysis of bacterial inhibition activity in airway secretions. a Example plots of children with different bacterial inhibition activities. The y-axis
represents the optical density which is directly related to the amount of bacterial (Streptococcus pneumoniae) growth: bacterial growth increases turbidity of
the culture media resulting in a proportional increase in optical density. The x-axis represents a doubling dilution of nasal samples from 1:20 to 1:40,960.
The dashed horizontal red line denotes an optical density cutoff above which substantial turbidity of the culture media was observed. Nasal secretions from
infant 1 were unable to inhibit bacterial growth at any dilution (bacterial inhibition index [BII]= 0). Nasal secretions from infant 2 completely inhibited
pneumococcal growth at dilutions≤ 1:160 (BII= 160). b Children were categorised into ﬁve BII strata and differences in the proportional abundance of
different bacterial taxa in each stratum presented in pie charts. The airway abundance of Streptococcus decreased with increasing bacterial inhibition
activity. c Bacterial inhibition activity in nasal samples (N= 72) was correlated with the expression levels of neutrophil-granule proteins (stratiﬁed by
functional subset). Representative proteins from all three subsets of neutrophil granules (azurophilic, speciﬁc and gelatinase) were positively correlated
with bacterial inhibition activity (complete analysis of the correlation between bacterial inhibition activity and all the neutrophil granule proteins can be
found in Supplementary Fig. 2). In contrast, there was no correlation between the expression levels of housekeeping proteins (ACTB, B2M and PPIA) and
bacterial inhibition activity in nasal samples. Correlation analysis was done using Spearman’s rank order correlation. d Bacterial inhibition activity was
compared between RSV-positive (N= 36) and RSV-negative children (N= 36). The mean BII level in RSV-infected children (geometric mean: 52) was
signiﬁcantly greater than the mean BII in RSV-negative children (geometric mean: 10.9). Error bars indicate 95% conﬁdence intervals. e Mean airway IgG
levels to two Streptococcus pneumoniae proteins (choline-binding protein D and Histidine Triad protein E) were compared between RSV-positive (N= 36)
and RSV-negative children (N= 36). Error bars indicate 95% conﬁdence intervals. P-values in d and e were based on Mann–Whitney U-test. Source data
are provided as a Source Data ﬁle
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neutrophils comprised 8% of cells in the upper airway (Fig. 4g).
Although the mean frequency of airway-resident neutrophils in
RSV-positive children was higher than that of RSV-negative
children, this difference was not statistically signiﬁcant. Next,
using an ex-vivo phagocytosis assay, we assessed the ability of
airway-resident neutrophils from RSV-positive and RSV-negative
bacteria to ingest and kill bacteria. In this assay, we used a
representative bacteria species (E. coli) that was labelled with a tag
(pHrodo) whose ﬂuorescence was activated only upon ingestion
and localisation of the bacteria into a phagosome, thereby
allowing for a quantitative assessment of phagocytic activity
through ﬂow cytometry (see examples in Fig. 4d, f). Using this
assay we compared the phagocytic capacity of airway neutrophils
obtained from RSV-positive and RSV-negative children.
Although not statistically signiﬁcant, a greater proportion of
airway neutrophils obtained from RSV-positive children exhib-
ited phagocytic activity against E. coli (median 18%) compared to
RSV-negative children (median 16%).
Degranulation is associated with lower oxygen saturation. In
order to identify a potential role for airway neutrophil granule
proteins in the pathogenesis of RSV, we examined the effect of
different protein expression levels on clinical parameters asso-
ciated with RSV disease severity. Since one of the central features
of severe RSV pneumonia is reduced blood oxygen saturation
resulting from occlusion of small airways with necrotic, virus-
infected cells as well as inﬁltrating immune cells. We therefore
examined the effect of the increased expression of neutrophil
granule proteins on blood oxygen saturation. Children were
dichotomised into two groups (high and low neutrophil granule
expressers) based on the median expression level of different
proteins. Children whose protein expression level was above the
median expression (of the full study population) were classiﬁed as
high expressers while those who were below the median were
classiﬁed as low expressers (Fig. 5). We then compared oxygen
saturation levels between these two groups. For all neutrophil
granule proteins that were analysed (ITGAM, BPI, LCN2,
MGAM, ITGB2, AZU1, ANPEP, MMP9 and MPO), children
with low levels of airway neutrophil granule expression had
signiﬁcantly higher blood oxygen saturation levels compared
to children in the high-expression group (Fig. 5a). For compar-
ison, we also dichotomised the expression levels of two house-
keeping proteins—beta-actin (ACTB) and β-2-microglobulin
Q1
2.39
Q2
45.8
Q3
7.22
Q4
E. coli–
82.2
E. coli+
17.8 E. coli–95.4
E. coli+
4.62
44.5
0
0
0
20
40
60
80
100
Q1
4.18
Q4
92.6
Q2
1.80
Q3
1.38
0
10
20
30
RSV-
negative
RSV-
positive
0
20
40
60
Fr
eq
ue
nc
y 
of
 a
irw
ay
n
e
u
tro
ph
ils
 
p = 0.8
RSV-
negative
RSV-
positive
4
8
16
32
64
128
Ex
-v
iv
o 
ne
ut
ro
ph
il
ph
ag
oc
yt
os
is
0.6
105
105
104
104
CD
66
b 
- P
er
CP
-C
y5
.5
CD
66
b 
- P
er
CP
-C
y5
.5
Co
un
t
Co
un
t
103
–103
100 μm
0
0
105
105
104
104
103
103
–103
–103
0 105104103–103
CD16b-PE-Texas Red
E. coli -pHrodo
0 105104103–103
E. coli -pHrodo
CD16b-PE-Texas Red
a c e g
b d f h
Fig. 4 Analysis of the cellular sources of the airway proteome by ﬂow cytometry. a Cells obtained from nasopharyngeal and oropharyngeal swabs (both
eluted in universal transport media) from a child with an RSV infection was visualised at ×200 magniﬁcation. Multiple cell morphologies including epithelial
cells were observed. b Upper airway sample obtained from an infant admitted to hospital with RSV-pneumonia was analysed using a direct
immunoﬂuorescent antibody test38 (Light Diagnostics, Merc). RSV-infected cells are shown emitting an apple-green ﬂuorescent signal, while uninfected
cells emit a red ﬂuorescent signal from a counterstain (Evans blue). Image taken using Nikon Eclipse ﬂuorescent microscope image acquisition software.
c Flow cytometry analysis was used to identify neutrophils in the sample described in b above (details of full gating strategy can be found in the “Methods”
section and in Fig. S5). Cells that were double positive for CD66b and CD16 were gated as neutrophils. d Phagocytic activity of airway-resident neutrophils
shown in c above was analysed using ﬂow cytometry. Cells were co-incubated with an E. coli strain that was labelled with a dye (pHrodo) whose
ﬂorescence was only activated upon phagocytosis. In this example, 17.8% of the neutrophils in the sample exhibited bacterial phagocytosis. e, f A similar
example is shown from a different child who had fewer neutrophils and also had reduced phagocytic activity. g The frequency of airway-resident
neutrophils in RSV-positive and RSV-negative children is shown as a proportion of all airway cells. The proportion of airway cells that were identiﬁed as
neutrophils was greater in RSV-positive children (N= 10) compared to RSV-negative children (N= 10) although the difference did not reach statistical
signiﬁcance. Error bars indicate 95% conﬁdence intervals about the geometric mean. h The capacity of airway neutrophils from RSV-positive (N= 10)
and RSV-negative (N= 10) children to phagocytose bacteria was compared. A greater proportion of neutrophils from RSV-positive children exhibited
phagocytic activity compared to RSV-negative children, although this difference did not achieve statistical signiﬁcance. Error bars indicate 95% conﬁdence
intervals about the geometric mean. Comparison between the RSV-positive and RSV-negative groups in g and h was conducted using the Mann–Whitney
U-test. Source data for g and h are provided as a Source Data ﬁle
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(B2M)—using the median. In contrast to the neutrophil granule
proteins, there was no difference in blood oxygen saturation
between high and low expressers of ACTB and B2M (Fig. 5b).
Discussion
RSV infection in infants and children has been associated with an
increased risk of secondary bacterial infections, such as otitis
media mainly due to secondary Streptococcus infection12–14. We
therefore hypothesised that the host response to RSV is partly
directed at controlling increased levels of Streptococcus. We
undertook comprehensive analysis of the airway microbiota and
proteomes of children with RSV as well as RSV-negative controls,
in order to identify features of the post-infection innate immune
response that have incidental antibacterial effects. We found that
the upper airways of children in the study was dominated by a
highly diverse population of commensal bacteria for which a wide
range of bacterial proteins could be detected in the airway
metaproteome. We also found evidence that infection with RSV is
associated with increased Streptococcal colonisation. In a subset
analysis of children who were sampled both during acute disease
and at convalescence, approximately one month later, we found
that the airway abundance of Streptococcus was greater at the time
of RSV infection compared with the convalescent time point
when children had cleared the infection. These results agree with
previous clinical studies that have shown that children with RSV
infections have a higher abundance of Streptococci in their airway
secretions19, and supports the idea that RSV-infection in the
human airway, enhances Streptococcal colonisation.
Our results showed that following an RSV infection there was a
signiﬁcant increase in the expression levels of a large number of
proteins related to innate immunity. Due to the fact that RSV
replication and the RSV-mediated increase in bacterial colonisa-
tion occur simultaneously, it was not possible to establish which
elements of this response were directly attributable to the virus
and which ones were triggered by the increased bacterial load.
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Fig. 5 Association between airway neutrophil granule expression and disease severity. In order to characterise the clinical implications of the increased
expression of neutrophil-associated proteins on disease pathology, we assessed the association between the level of expression of these proteins and a
cardinal feature of RSV pathology, blood oxygen saturation. a Using proteome data obtained from all admitted children (n= 84), we stratiﬁed the
expression levels of nine neutrophil granule proteins (ITGAM, BPI, LCN2, MGAM, ITGB2, AZU1, ANPEP, MMP9 and MPO) that were signiﬁcantly over-
expressed in RSV-infected children by the median. Children whose protein expression level was above the population median were classiﬁed as high-
expressers while those below it were classiﬁed as low expressers (see legend for graphical illustration of the stratiﬁcation strategy). For all proteins
analysed, children in the high expression group had signiﬁcantly lower blood oxygen saturation levels (measured using ﬁngertip pulse oximetry) compared
to children in the low expression group. b For comparison, we used the same median stratiﬁcation strategy to dichotomise children into high and low
expression groups for two housekeeping control proteins, beta-actin (ACTB) and beta-2-microglobulin (B2M). For both proteins there was no statistically
signiﬁcant difference in blood oxygen saturation levels between high and low expressers. The dashed horizontal line indicates an oxygen saturation
threshold of 90%, below which children would typically be characterised as functionally hypoxic. Statistical comparison between high and low strata was
done using a two-sided Student t-test. The elements of the box and whisker plots are deﬁned in Fig. 1. Source data are provided as a Source Data ﬁle
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Since the innate host response to infection is highly co-ordinated,
and the proteins that were highly expressed in RSV-positive
children are likely to represent functionally related proteins that
are co-regulated in order to initiate an effector response, we
used pathway enrichment analysis to identify the innate immune
pathways that were associated with the highly expressed proteins.
In RSV-infected children, we found a signiﬁcant enrichment of
the neutrophil degranulation pathway, characterised by the
increased expression of neutrophil effector proteins, such as
MPO, AZU1 and ELANE which have been shown in previous
work to be associated with RSV infection23–25. In agreement with
previous studies26,27, we found that neutrophils could be detected
at relatively high frequencies in the upper airway samples of
children with respiratory infections, thereby suggesting that the
local innate response to RSV infection in the airway is associated
with an inﬂux of neutrophils and their subsequent degranulation.
Neutrophils are specialised innate phagocytic cells that are den-
sely packed with granules containing hundreds of proteins with
broad antibacterial action28. These granules can be broadly
classiﬁed into three subsets29: primary (or azurophil) granules
(characterised by expression of MPO, BPI and ELANE), sec-
ondary (or speciﬁc) granules (characterised by LCN2 expression)
and tertiary (or gelatinase) granules (identiﬁed by expression of
MMP9). In this study, we identiﬁed proteins belonging to all
three subsets in the upper airway secretions of study participants
and all were expressed at signiﬁcantly higher levels in RSV-
infected children compared to RSV-negative controls. Previous
studies have provided compelling evidence of the direct anti-
bacterial action of neutrophil granule proteins and have high-
lighted their central role in innate immune defence against
bacteria. For example, MPO is a potent bactericidal protein,
which in the presence of a hydrogen peroxide (H2O2) source—
such as S. pneumoniae30—selectively binds to bacteria, such as
Escherichia coli, Pseudomonas aeruginosa, S. aureus and Strepto-
coccus pyogenes, causing their rapid killing31. BPI on the other
hand exhibits independent antibacterial activity against Gram-
negative bacteria such as E. coli32,33 and is also capable of neu-
tralising bacterial endotoxin34, while ELANE mediates cleavage of
virulence factors from bacteria such as Salmonella and Shigella35.
In addition to neutrophil granule proteins, we found increased
expression of bactericidal proteins from other innate immune cell
populations, such as the eosinophilic peroxidase EPX, which
rapidly kills bacteria such as Mycobacterium tuberculosis36. These
observations suggested that the neutrophil response that follows
an RSV airway infection might have signiﬁcant antibacterial
activity due to the incidental overexpression of these bactericidal
proteins. To test this hypothesis, we compared the relative bac-
terial inhibition activity in airway samples obtained from RSV-
positive and RSV-negative children, as well as a subset of RSV-
infected infants from whom acute and convalescent samples were
available. We found that the airway secretions from children
infected with RSV had signiﬁcantly higher bacterial inhibition
activity compared with those from RSV-negative children.
Additionally, bacterial inhibition activity at the acute stage of RSV
infection, was signiﬁcantly greater than during convalescence.
Furthermore, there was a positive correlation between the
expression levels of neutrophil granule proteins and inhibition of
pneumococcal growth in the in vitro bacterial inhibition assay.
We also found that an increase in bacterial inhibition activity was
associated with changes in the composition of the upper airway
microbiota, characterised by a reduction in the airway abundance
of Streptococcus. Comparative analysis of the relative levels of
anti-pneumococcus IgG in RSV-positive and RSV-negative chil-
dren showed that the difference in bacterial inhibition activity
could not be explained by a differential abundance of these
antibodies, since antibody levels against two different
pneumococcal antigens were not signiﬁcantly different. Taken
together these observations suggest that the recruitment and
degranulation of airway neutrophils in following an RSV infec-
tion is associated with the increased expression of bactericidal
proteins whose antibacterial action contributes to the regulation
of commensal bacteria in the upper respiratory tract. Due to the
fact that the virus-mediated increase in bacterial load occurs
concurrently with the airway replication of RSV, it was not
possible to conclusively establish whether the antibacterial activity
that we observed in RSV-infected children was as a result of
virus infection, increased bacterial load or both. Despite the
fact that nasal secretions from RSV-infected children had sig-
niﬁcantly greater antibacterial activity compared to RSV-negative
controls, these children had a higher airway abundance of
Streptococcus. A possible explanation for this observation is the
contemporaneous nature of RSV replication and increased bac-
terial colonisation in the airway. Previous studies in in vitro cell
culture models have shown that S. pneumoniae adheres at sig-
niﬁcantly greater levels to RSV-infected cells, compared to
uninfected cells and that this increased adherence is mediated
by a direct interaction between bacterial adhesins and the RSV
attachment protein that is expressed on the surface of RSV-
infected cells15,16,18. This suggests that the conditions in the
airway at the time of acute RSV infection—when virus replication
is at peak—favour increased bacterial colonisation and that these
conditions persist for as long as the viral infection remains
unresolved.
In order to characterise the clinical implications of neutrophil-
mediated inﬂammation and degranulation on the pathology of
RSV disease, we examined the association between the expression
level of neutrophil granule proteins and a key feature of RSV
disease pathology, reduced blood oxygen saturation. For all the
proteins that we analysed, we found that increased expression of
neutrophil granule proteins in the airway was associated with
reduced oxygen saturation. These observations suggest that the
inﬂux of neutrophils in the airway and their subsequent degra-
nulation may play a substantial role in the pathology of RSV
disease. Despite over 60 years of research, remarkably little is
known about the cellular response to RSV in the lungs of infants.
The most detailed study to date examined archived post-mortem
lung tissue from suspected fatal cases of RSV bronchiolitis from
the 1930s and 1940s. Lung tissue obtained from these infants was
characterised by a neutrophil inﬂux that was distributed pre-
dominantly between arterioles and airways37. Using modern
systems biology tools, our results of our study align with these
previous ﬁndings and highlight a potential central role of neu-
trophils in RSV disease pathology. It is likely that these inﬁltrating
neutrophils occlude the small airways of young infants, leading to
impaired gas exchange and manifesting clinically in reduced
blood oxygen saturation and hypoxia.
Using ﬂow cytometry analysis we found that airway samples
obtained from RSV-infected children had a greater abundance of
neutrophils compared to those from RSV-negative children,
although this difference did not reach statistical signiﬁcance. We
also found that a greater proportion of neutrophils from RSV-
infected children exhibited phagocytic activity against bacteria,
although the difference was also not signiﬁcant. A potential
explanation of these results is the relatively small sample size used
in the cellular analysis.
A further limitation of this study is the fact that the interac-
tions between the host, virus and resident microbiota were stu-
died in the upper airway. Since the pathogenesis of pneumonia is
limited to the lower respiratory tract, future studies should aim to
examine these interactions using samples derived from the lung.
Such studies may provide a unique opportunity to examine the
mechanistic basis for serious respiratory infections such as RSV.
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Methods
Study site and population. The study was conducted in Kiliﬁ County, a pre-
dominantly rural community on the Kenyan coast. The study population was
recruited from local healthcare facilities including the Kiliﬁ County Hospital and
the Pingilikani dispensary. Nasopharyngeal and oropharyngeal swabs were col-
lected and used for multiplex PCR diagnosis of 15 respiratory pathogens: RSV
(A and B), rhinovirus, parainﬂuenza virus (1, 2, 3 and 4) adenovirus, inﬂuenza
(A, B and C), coronavirus (OC43 and e229), human metapneumovirus and M.
pneumoniae. Results from RSV-positive samples were conﬁrmed using a direct
ﬂuorescent antibody test kit (Light Diagnostics, Merc) in accordance with the
manufacturer’s instructions. A standardised set of clinical and anthropometric
measures were collected for all study participants including: age, respiratory rate,
axillary temperature, oxygen saturation, and history of upper respiratory tract
symptoms (coughing, sneezing, runny nose). To establish associations between
RSV infection and the resident airway microbiota, children were stratiﬁed into
two groups, RSV-positive and RSV-negative: in the RSV-positive group, only
children who were positive for RSV (real-time cycle threshold values ≤ 27) and
negative for all other targets on the multiplex panel were included. In the RSV-
negative group, only children who were negative for all pathogens in the real-time
PCR panel were included. Children with positive blood culture results were
excluded from the study. Written informed consent was sought from the parents
and legal guardians of all children who were sampled in this study. Ethical approval
for the conduct of this study was granted by the Kenya Medical Research Institute’s
Scientiﬁc and ethical research unit (SERU). All study procedures were conducted
in accordance with Good Clinical Laboratory Practise (GCLP) standards. All
measurements reported in this paper were obtained from individual children
sampled once, with the exception of a subset of 10 children who were sampled
during acute disease and at convalescence in order to examine the effect of RSV
infection on Streptococcal colonisation.
Sequencing of the bacterial 16S rRNA gene. The swabs that were collected from
each study participant were initially stored at −80 °C. For DNA extraction, samples
were retrieved from storage, thawed on ice and cell pellets obtained by centrifuging
samples for 10 min at 17,000×g, after which they were washed once using sterile
phosphate buffered saline (PBS). 350 μl of a cell lysis buffer (RLT, qiagen) sup-
plemented with β-mercaptoethanol (1%) was added to the pellet and vortexed
brieﬂy to break up the pellet. Glass beads were then added to the sample and
homogenisation was done by vortexing at maximum speed for 1 min. DNA
extraction from the cell homogenate was done using the AllPrep RNA/DNA/
Protein kit (Qiagen), following the manufacturer’s instructions. DNA yields were
quantiﬁed using a Qubit 2.0 ﬂuorometer (Thermo Fisher).
The V3–V4 hypervariable region of the 16S rRNA gene was targeted for
sequencing. Primers targeting this region were constructed with Illumina
adaptor overhang sequences added to the gene-speciﬁc primer sequences. A region
of ≈550 bp was targeted and ampliﬁed using the 341F (5′-CCTACGGGNGGCWG
CAG-3′) and 785R (5′-GACTACHVGGGTATCTAATCC-3′) primers appended
with Illumina adaptor sequences. Ampliﬁcations were done in 25 µl reactions with
12.5 µl Q5® Hot Start High-Fidelity 2X Master Mix (NEB), 1 µl of 1 µM forward
and reverse 16S Amplicon PCR primer and 2.5 µl of template. The reactions were
performed on ABI Veriti thermocyclers (Applied Biosytems) under the following
conditions: 95 °C for 3 min, 25 cycles of: 95 °C for 30 s, 55 °C for 30 s, 72 °C for 30 s,
followed by 72 °C for 5 min and a ﬁnal hold at 4 °C. The ampliﬁed products were
then veriﬁed on 1% agarose gel before purifying using Agencourt AMPure XP
beads (Beckman Coulter). A negative dH2O control was incorporated into the
entire experimental workﬂow and analysed by agarose gel electrophoresis in order
to ensure that the workﬂow was free of extraneous bacterial contamination. This
control was also included in subsequent library preparation and sequencing steps
and conﬁrmed to be free of extraneous bacterial contamination.
Libraries were prepared by ligating Illumina dual indices and Illumina-
sequencing adaptors to the prepared amplicons using the NexteraXT index kit.
Attachment of the indices was performed using 5 μl of the 16S amplicon DNA, 5 μl
of Illumina Nextera XT Index Primer 1 (N7xx), 5 μl of Nextera XT Index Primer 2
(S5xx), 25 μl of Q5® Hot Start High-Fidelity 2X Master Mix (NEB), and 10 μl of
PCR-grade water (Ambion). The reactions were performed on ABI Veriti
thermocyclers (Applied Biosytems) under the following conditions 95 °C for 3 min,
followed by eight cycles of: 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 30 s, and a
ﬁnal extension at 72 °C for 5 min and a ﬁnal hold at 4 °C. Each library was then
puriﬁed using Agencourt AMPure XP beads (Beckman Coulter), and thereafter the
size distribution and library quality control were carried out using the Agilent 2100
Bioanalyzer (Agilent) to conﬁrm the expected size distribution and the quality. The
libraries were quantiﬁed using the Qubit 2.0 ﬂuorometer (Life Technologies). The
barcoded libraries were normalised and pooled at equimolar concentration based
on the Qubit results and 8 pM of the pooled library spiked with 5% Phix (v3) for
sequencing. Sequencing was done on the Illumina MiSeq system using 2 × 300 bp
PE sequencing with the MiSeq® Reagent Kit v3 (600 cycles).
Analysis of the airway microbiome. A customised Python-based Quantitative
Insights Into Microbial Ecology 2 (https://qiime2.org/)—QIIME239,40—workﬂow
was adopted for analysis of raw Illumina reads and generation of the sequence
table. Sequence quality control and feature table construction was done using
DADA241: low-quality sequencing reads were ﬁltered out by trimming the reads at
the nucleotide position at which a substantial drop in quality was observed. Error
estimation, de-replication, construction of the sequence table and removal of
chimeras was done using default DADA2 parameters. Taxonomies were assigned
to the sequence table using a pre-trained Naïve Bayes classiﬁer. The classiﬁer was
trained on the Greengenes42 13_8 99% OTUs in which sequences were trimmed to
represent the 16S region spanning 341F/785R V3/V4 primer pair. The sequence
data have been submitted to the European Nucleotide Archive database
(PRJEB28053).
Analysis of the airway proteome. The host airway proteomes of children in
this study were characterised in nasopharyngeal and oropharyngeal swabs
using high-performance liquid chromatography–tandem mass spectrometry
(HPLC–MS/MS)43. A detailed description of this method can be found in Sup-
plementary methods. The data arising from the mass-spectrometry analysis are
deposited in the ProteomeXchange Consortium database44 (Accession number:
PXD009403). Analysis of the airway metaproteome was undertaken by searching
the Raw mass spectrometer ﬁles (using MaxQuant software version 1.6.0.131)
against a bacterial FASTA database, which was constructed by assembling Uniprot
FASTA ﬁles of individual bacteria species that had been identiﬁed by genomic
microbiota analysis into a single FASTA search ﬁle. Searches for bacterial proteins
were done using the Andromeda search engine45. To test whether the mean
expression levels of different host airway proteins were signiﬁcantly different
between RSV-positive and RSV-negative children, two-sided t-tests were conducted
and adjustment for multiple testing done using the false discovery rate (fdr)
method. Proteins were signiﬁcantly differentially expressed if their mean expres-
sion level in one group was at least 1.5-fold greater than in the alternative group.
GO biological pathway enrichment analysis was done on the enrichR bioinformatic
pipeline46,47. The output of this analysis was used to determine whether certain
biological pathways were statistically overrepresented in the airway secretions of
RSV-positive or RSV-negative children. The difference between the blood oxygen
saturation levels of children with high (above median) neutrophil granule
expression levels and those of children with low (below median) expression levels
was analysed using Mann–Whitney test.
Bacterial inhibition assay. Using a pure overnight culture of S. pneumoniae
0.5 McFarland bacterial suspension was prepared in Mueller–Hinton broth with
Tris ethylenediaminetetraacetic acid sodium dodecyl sulfate (TES) buffer (Thermo-
ﬁsher) and standardised using a nephelometer. 100 µl of the suspension was
transferred to a tube of Mueller–Hinton broth containing lysed horse blood. 50 µl
of a 1:32 dilution of this mixture in minimum essential medium (MEM; Sigma
Aldrich) was then added to the wells of a U-bottomed 96-well plate. Nasal samples
whose bacterial inhibition activity was to be measured were prepared as follows:
500 µl of raw nasopharyngeal and oropharyngeal swabs eluted in universal trans-
port media (Copan diagnostics) were centrifuged at 17,000×g for 10 min and
supernatants obtained. The supernatants were further spun at 17,000×g for 30 min
on 3k Amicon centrifugal ﬁlter devices (Merck), to remove low molecular weight
compounds (≤3 kDa). For each sample, the resulting concentrate was diluted over a
12-step doubling dilution series ranging from 1:20 to 1:40,960 in MEM. 50 µl of this
preparation was then added to the plate containing the bacterial solution that
had been prepared earlier and the plates were then incubated for 36 h in a 37 °C
incubator. After the incubation, the plates were visually inspected by two inde-
pendent readers to determine the highest sample dilution at which bacterial growth
was completely inhibited. The reciprocal of this dilution was referred to as the
bacterial inhibition index (BII). Plates were also read on an optical microplate
reader (BioTek) and optical densities at 630 nm determined. The correlation
between airway protein expression level and bacterial inhibition activity was
examined using Spearman’s correlation analysis while the difference in bacterial
inhibition activity between RSV-positive and RSV-negative children was tested
using the Wilcoxon signed-rank test.
Analysis of Pneumococcal antibodies in airway secretions. Two conserved
pneumococcal antigens, pneumococcal histidine triad protein E48 and choline-
binding protein D48 were expressed as synthetic peptides and dissolved in a
solution containing 70% dimethyl sulfoxide, 5% glycerol and 25% sodium acetate
(pH 4.5). Each antigen was spotted on a functionalized Epoxy glass slide using a
non-contact Inkjet microarray printer (Array jet). Slides were then dried at room
temperature (RT) for 48 h and subsequently loaded onto hybridisation cassettes
where they were initially washed twice with PBS containing Tween-20 and then
twice with PBS only. Blocking was done for 1 h using 5% bovine serum albumin
(BSA) in 1× saline sodium citrate (SSC) buffer (pH 7.0) containing 0.25% sodium
dodecyl sulfate (SDS) and 4.5% sodium chloride (NaCl). Blocked slides were
incubated at 41 °C on a shaking platform. Nasal samples from study participants
were ﬁrst spun at 17,000×g for 5 min to obtain supernatants which were then
ﬁltered on 3K Amicon centrifugal ﬁlter devices (Merck). The resulting concentrates
were supplemented at a 1:1 ratio with 5% BSA in PBS containing Tween-20. A total
of 50 µl of this solution was added onto hybridisation cassette wells and the slides
incubated for 4 h at 4 °C on a shaking platform. After incubation, slides were
washed as before. 1:500 dilutions of secondary antibodies—goat anti-human IgA
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conjugated to Alexa-ﬂuor 555 (Southern biotech) and goat anti-human IgG con-
jugated to Alexa ﬂour 647 (Invitrogen)—were mixed together and then added onto
the slides, which were left to incubate for 1 h at 25 °C. Following the incubation,
slides were washed as above, disassembled from the cassettes, rinsed using Milli-Q
water and spun dry for 5 min using a slide spinner. Slides were then read on a
GenePix 4300A microarray scanner (Molecular devices). Pneumococcus-speciﬁc
antibody levels against the two antigens were calculated automatically by the
scanner software and expressed as background-corrected median ﬂuorescence
intensities (corrected median MFI). The difference in the levels of pneumococcus
IgG between RSV-positive and RSV-negative children was tested using the
Wilcoxon signed-rank test.
Flow cytometry analysis of upper airway cells. One millilitre of nasopharyngeal
and oropharyngeal swab samples obtained from children was centrifuged at
17,000×g for 7 min, after which 800 μl of the supernatant was removed and dis-
carded. The remaining 200 μl were split into two aliquots of 100 μl each. The ﬁrst
aliquot was used for neutrophil phenotyping assays and the other was used for
neutrophil phagocytosis assays. A volume of 20 μl of a pre-constituted cocktail of
the following antibodies (from ThermoFisher) was used to label both aliquots—
CD45, CD16, CD14, CD3, CD19, HLA-DR, CD66b, CD11b and a Live–dead
marker. With the exception of the live/dead marker, all other antibodies were
diluted 1:100 in FACS buffer. The live/dead marker was prepared at a 1:1000
dilution in FACS buffer. For the phagocytosis assay tube, 20 μl of opsonised E. coli
was added to the tube (pHrodo Red E. coli BioParticles; ThermoFisher). The
bacteria was initially prepared by mixing the E.coli strain with new-born calf sera
followed by a 30-min incubation at 37 °C. After this step, both tubes were incu-
bated at 37 °C for 35 min. After the incubation, 20 μl of a live–dead marker was
added to each tube and incubated for 10 min at 37 °C. The reaction was stopped by
adding 500 μl of 1X RBC lysis buffer followed by a 5 min incubation. Cells in each
tube were then spun down at 2700×g for 1 min and the supernatant discarded.
Cells were then washed twice with FACS buffer, after which 350 μl of FACS ﬂow
was added. Cells were then analysed immediately on a BD LSR Fortessa instru-
ment. The following gating strategy was used to detect airway-resident neutrophils:
Debris were excluded on the basis of their forward (FSC-A) and side (SSC-A)
scatter characteristics (Supplementary Fig. 5a). Doublets were excluded using FSC-
A versus FSC-H (Supplementary Fig. 5b) and dead cells were excluded using the
live–dead marker (Supplementary Fig. 5c). Cells that were double positive for
CD66b and CD16 were gated as neutrophils (Supplementary Fig. 5e). Cells in this
gate were further analysed for their ability to phagocytose a representative bacteria
(E. coli) and the results expressed in a histogram plot (Supplementary Fig. 5d).
Data was analysed using FlowJo software.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data underlying Figs. 1a, 1b, 1c, 1d, 2a, 2b, 2c, 2d, 2e, 3a, 3b, 3c, 3d, 3e, 4g, 4h, 5, and
Supplementary Figs. 1, 2, 3a and 3b are provided as Source Data ﬁles. The proteomics
and metagenomics data sets containing all the raw data and associated metadata
underlying Figs. 1a, 1b, 1c, 1d, 2a, 2b, 2c, 2d, 2e, 3b, 3c and Supplementary Figs. 1, 2, 3
and 4 are uploaded on ProteinXchange and the European Nucleotide archive databases
with the accession numbers PXD009403 and PRJEB28053, respectively. All other data are
available from the corresponding author upon reasonable requests.
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